F. Y. Lee

Rapid mobilization of cytotoxic lymphocytes induced by dasatinib therapy

Satu Mustjoki, Kaisa Auvinen, Anna Kreutzman et al. · Leukemia · 2012 · 93 citations

Medicine, Hematology, Oncology +8

Synergistic growth-inhibitory effects of two tyrosine kinase inhibitors, dasatinib and PKC412, on neoplastic mast cells expressing the D816V-mutated oncogenic variant of KIT

Karoline V. Gleixner, Matthias Mayerhofer, Karoline Sonneck et al. · Haematologica · 2007 · 90 citations · Full text

Medicine, Oncology, Pharmacology +17

Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograft

Feng Luo, Zheng Yang, Huijing Dong et al. · Cancer Chemotherapy and Pharmacology · 2005 · 87 citations

Medicine, Oncology, Pharmacokinetics +11

Ixabepilone (BMS-247550) plus trastuzumab combination chemotherapy induces synergistic antitumor efficacy in HER2 dependent breast cancers and is accompanied by modulation of molecular response markers

F. Y. Lee, Stephen Castaneda, Ivan Inigo et al. · Journal of Clinical Oncology · 2005 · 32 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Preclinical efficacy evaluation of ixabepilone (BMS-247550) in combination with cetuximab or capecitabine in human colon and lung carcinoma xenografts

F. Y. Lee, Amy Camuso, Stephen Castenada et al. · Journal of Clinical Oncology · 2006 · 30 citations

Medicine, Oncology, Pharmacology +14